Peptidyl nitroalkene inhibitors of main protease rationalized by computational and crystallographic investigations as antivirals against SARS-CoV-2.

Communications chemistry, 2024, 7, 15.

Medrano, F.J.; de la Hoz-Rodríguez, S.; Martí, S.; Arafet, K.; Schirmeister, T.; Hammerschmidt, S.J.; Müller, C.; González-Martínez, Á.; Santillana, E.; Ziebuhr, J.; Romero, A.; Zimmer, C.; Weldert, A.; Zimmermann, R.; Lodola, A.; Świderek, K.; Moliner, V.; González, F.V.

Peptidyl nitroalkene inhibitors of main protease rationalized by computational and crystallographic investigations as antivirals against SARS-CoV-2..

Article page: https://www.nature.com/articles/s42004-024-01104-7